Juniper Pharmaceuticals (Nasdaq: JNP) is focused on developing therapeutics that address unmet medical needs in women's health. Juniper is accelerating development of its proprietary product pipeline, leveraging in-house formulation, pharmaceutical development, and manufacturing. R&D is substantially funded by cash flow generated by the CRINONE franchise and the contract pharmaceutical services provided by Juniper Pharma Services. Pipeline products utilize Juniper’s novel drug delivery technologies, including a segmented intravaginal ring (IVR) developed in the laboratories of Dr. Robert Langer at MIT and Dr. William Crowley at Mass. General Hospital. The Company is advancing IVR candidates for overactive bladder in women, HRT for symptoms of menopause, and prevention of preterm birth in women with a short cervical length. Juniper's commercial product, CRINONE® 8% (progesterone gel), is marketed by Merck KGaA, Darmstadt, Germany, in over 90 countries worldwide and by Allergan, Inc. in the U.S..
View Top Employees from Juniper Pharmaceuticals, Inc.Website | https://www.juniperpharma.com |
Ticker | NASDAQ:JNP |
Employees | 65 (16 on RocketReach) |
Founded | 1997 |
Phone | +1 617-639-1500 |
Technologies |
JavaScript,
HTML,
PHP
+48 more
(view full list)
|
Industry | Pharmaceuticals, Biotechnology, Specialty pharmaceutical company with a focus on women's health, Science and Engineering, Therapeutic Devices, Contract pharmaceutical services provided by Juniper Pharma Serv |
Web Rank | 24 Million |
Keywords | Jnp-0201 |
Looking for a particular Juniper Pharmaceuticals, Inc. employee's phone or email?
Claire Madden-Smith is the Senior Vice President Juniper Pharma Services of Juniper Pharmaceuticals, Inc..
16 people are employed at Juniper Pharmaceuticals, Inc..
Juniper Pharmaceuticals, Inc. is based in Nottingham, Nottingham.